Estimating the burden of disease attributable to diabetes in South Africa in 2000

被引:21
作者
Bradshaw, Debbie [1 ]
Pieterse, Desiree [1 ]
Norman, Rosana [1 ]
Levitt, Naomi S. [2 ]
机构
[1] South African Med Res Council, Burden Dis Res Unit, Cape Town, South Africa
[2] Univ Cape Town, Dept Med, Cape Town, South Africa
关键词
D O I
10.1080/22201009.2007.10872159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To estimate the burden of disease attributable to diabetes by sex and age group in South Africa in 2000. Design. The framework adopted for the most recent World Health Organization comparative risk assessment (CRA) methodology was followed. Small community studies used to derive the prevalence of diabetes by population group were weighted proportionately for a national estimate. Population- attributable fractions were calculated and applied to revised burden of disease estimates. Monte Carlo simulation-modelling techniques were used for uncertainty analysis. Setting. South Africa. Subjects. Adults 30 years and older. Outcome measures. Mortality and disability-adjusted life years (DALYs) for ischaemic heart disease (IHD), stroke, hypertensive disease and renal failure. Results. Of South Africans aged >= 30 years, 5.5% had diabetes which increased with age. Overall, about 14% of IHD, 10% of stroke, 12% of hypertensive disease and 12% of renal disease burden in adult males and females (30+ years) were attributable to diabetes. Diabetes was estimated to have caused 22 412 (95% uncertainty interval 20 755 - 24 872) or 4.3% (95% uncertainty interval 4.0 - 4.8%) of all deaths in South Africa in 2000. Since most of these occurred in middle or old age, the loss of healthy life years comprises a smaller proportion of the total 258 028 DALYs (95% uncertainty interval 236 856 - 290 849) in South Africa in 2000, accounting for 1.6% (95% uncertainty interval 1.5 - 1.8%) of the total burden. Conclusions. Diabetes is an important direct and indirect cause of burden in South Africa. Primary prevention of the disease through multi-level interventions and improved management at primary health care level are needed.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 46 条
[1]  
Bah S, 2005, SAMJ S AFR MED J, V95, P902
[2]   Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria [J].
Borch-Johnsen, K ;
Neil, A ;
Balkau, B ;
Larsen, S ;
Nissinen, A ;
Pekkanen, J ;
Tuomilehto, J ;
Jousilahti, P ;
Lindstrom, J ;
Pyörälä, M ;
Pyörälä, K ;
Eschwege, E ;
Gallus, G ;
Garancini, MP ;
Bouter, LM ;
Dekker, JM ;
Heine, RJ ;
Nijpels, HG ;
Stehouwer, CDA ;
Feskens, EJM ;
Kromhout, D ;
Peltonen, M ;
Pajak, A ;
Eriksson, J ;
Qiao, Q .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) :397-405
[3]  
Chaturvedi N, 1996, BMJ-BRIT MED J, V313, P848
[4]   The answer to diabetes prevention: Science, surgery, service delivery, or social policy? [J].
Colagiuri, Ruth ;
Colagiuri, Stephen ;
Yach, Derek ;
Pramming, Stig .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2006, 96 (09) :1562-1569
[5]   The relationship between glucose and incident cardiovascular events [J].
Coutinho, M ;
Gerstein, HC ;
Wang, Y ;
Yusuf, S .
DIABETES CARE, 1999, 22 (02) :233-240
[6]   Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment [J].
Danaei, Goodarz ;
Lawes, Carlene M. M. ;
Hoorn, Stephen Vander ;
Murray, Christopher J. L. ;
Ezzati, Majid .
LANCET, 2006, 368 (9548) :1651-1659
[7]   Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality - The Multiple Risk Factor Intervention Trial experience [J].
Eberly, LE ;
Cohen, JD ;
Prineas, R ;
Yang, LF .
DIABETES CARE, 2003, 26 (03) :848-854
[8]   Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies [J].
Evans, JMM ;
Wang, JX ;
Morris, D .
BRITISH MEDICAL JOURNAL, 2002, 324 (7343) :939-942A
[9]   Selected major risk factors and global and regional burden of disease [J].
Ezzati, M ;
Lopez, AD ;
Rodgers, A ;
Vander Hoorn, S ;
Murray, CJL .
LANCET, 2002, 360 (9343) :1347-1360
[10]  
Gillum RF, 1999, AM J EPIDEMIOL, V150, P1266